Table 1 |
|||
|
The comparative pre- operative data from the patients both groups. |
|||
|
Group A |
Group B |
p |
|
|
|
|||
|
General characteristics |
|||
|
Number of patients |
25 |
25 |
- |
|
Male/female |
20/5 |
21/4 |
1 |
|
Age (y/s) |
66 ± 13 |
62 ± 15 |
0,319 |
|
Height (cm) |
164 ± 9 |
168 ± 11 |
0,166 |
|
Weight (kg) |
75 ± 11 |
72 ± 8 |
0,276 |
|
BSA |
1.74 ± 7.4 |
1.82 ± 6.6 |
0,968 |
|
Clinical preoperative data |
|||
|
Hypertension |
16 |
14 |
0.773 |
|
Diabetes mellitus |
8 |
10 |
0.769 |
|
Euroscore |
4.8 ± 2.2 |
4.5 ± 2.6 |
0,662 |
|
3-coronary vessel disease |
19 |
17 |
0.754 |
|
2-coronary vessel disease |
6 |
9 |
0.538 |
|
Significant Left main CAD |
2 |
4 |
0.667 |
|
Ischemic mitral regurgitation 1+/4+ |
7 |
4 |
0.496 |
|
Ischemic mitral regurgitation 2+/4+ |
4 |
8 |
0.321 |
|
Ejection fraction 30-35% |
9 |
12 |
0.567 |
|
Ejection fraction 35-40% |
16 |
13 |
0.567 |
|
Cardiac Index (L/min/m2) |
3.1 ± 0,6 |
3.2 ± 0.8 |
0,619 |
|
PCWP < 15 |
9 |
10 |
0.773 |
|
PCWP > 15 |
16 |
15 |
0.773 |
|
Preoperative medication |
|||
|
aMEA |
25 |
25 |
- |
|
b-blockers |
14 |
17 |
0.377 |
|
Calcium channel blockers (pts) |
11 |
8 |
0.561 |
|
|
|||
|
Papadopoulos et al. Journal of Cardiothoracic Surgery 2010 5:17 doi:10.1186/1749-8090-5-17 |
|||
